Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_assertion type Assertion NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_head.
- NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_assertion description "[We did, however, observe a modest increased risk among carriers of the transcobalamin (TCN) II 259 Pro/Arg + Arg/Arg variant (odds ratio 1.48, 95% confidence interval 1.09-2.02) for colorectal adenoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_provenance.
- NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_assertion evidence source_evidence_curated NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_provenance.
- NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_assertion SIO_000772 17389618 NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_provenance.
- NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_assertion wasDerivedFrom ctd_human-20130708 NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_provenance.
- NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_assertion wasGeneratedBy ECO_0000218 NP31432.RAabfFdorvsqqXaVJviITtaR85zwGkYLzUeoyNDANH2q0130_provenance.